.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Out-of-office blood-pressure monitoring can improve both diagnosis and ongoing treatment of hypertension by distinguishing sustained hypertension from white-coat and masked patterns. Home monitoring has the additional advantage of generating repeated measurements across several days, reducing the influence of a single clinic reading. For internists, structured home BP protocols can be especially valuable when adjusting medication, assessing resistant hypertension or investigating discordant office and ambulatory readings. Patients should use validated upper-arm devices with the correct cuff size and receive instruction on posture, rest period and repeated measurements. The data should be reviewed within a defined management plan, because monitoring without clinician response adds little value. Home BP also creates an opportunity to improve patient engagement by making treatment response visible. The practical message is straightforward: better measurement can prevent both overtreatment and undertreatment and can make hypertension care more data-driven without requiring expensive technology.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Out-of-office blood-pressure monitoring can improve both diagnosis and ongoing treatment of hypertension by distinguishing sustained hypertension from white-coat and masked patterns. Home monitoring has the additional advantage of generating repeated measurements across several days, reducing the influence of a single clinic reading. For internists, structured home BP protocols can be especially valuable when adjusting medication, assessing resistant hypertension or investigating discordant office and ambulatory readings. Patients should use validated upper-arm devices with the correct cuff size and receive instruction on posture, rest period and repeated measurements. The data should be reviewed within a defined management plan, because monitoring without clinician response adds little value. Home BP also creates an opportunity to improve patient engagement by making treatment response visible. The practical message is straightforward: better measurement can prevent both overtreatment and undertreatment and can make hypertension care more data-driven without requiring expensive technology.
4 weeks back
A bioengineered oral nanozyme microsupplement converts pathological ROS into a protective polydopamine hydrogel shield. By curbing neutrophil extracellular traps and balancing T cells, this platform outperforms standard 5-ASA in preclinical colitis models, opening new paths for sustained remission.
4 days back
Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
4 weeks back
Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
5 days back
A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
4 days back
Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
5 days back
